Schizophrenia Research Forum - A Catalyst for Creative Thinking
Home Profile Membership/Get Newsletter Log In Contact Us
 For Patients & Families
What's New
Recent Updates
SRF Papers
Current Papers
Search All Papers
Search Comments
Research News
Conference News
Plain English
Current Hypotheses
Idea Lab
Online Discussions
Virtual Conferences
What We Know
Animal Models
Drugs in Trials
Research Tools
Community Calendar
General Information
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
SRF Team
Advisory Board
Support Us
How to Cite
Fan (E)Mail
The Schizophrenia Research Forum web site is sponsored by the Brain and Behavior Research Foundation and was created with funding from the U.S. National Institute of Mental Health.
Research News
back to News Search
Probing the Role of NMDA Receptor NR2B in Development and Schizophrenia

5 January 2012. The NR2B subunit of the N-methyl-D-aspartate (NMDA) receptor plays a crucial role in the development and function of the cortex, according to a new report in the December 8 issue of Neuron. Led by Benjamin Hall of Tulane University in New Orleans, Louisiana, a team of researchers created a mouse model in which the NR2B subunit of the NMDA receptor was genetically replaced by the NR2A subunit. They observed altered α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor signaling in these animals, as well as a behavioral phenotype reminiscent of schizophrenia.

The glutamate hypothesis of schizophrenia, which posits dysfunction of the NMDA receptor (see SRF Current Hypothesis), is based, in part, on the observation that NMDA receptor antagonists can reproduce symptoms of the illness, and the fact that many genes reported to confer risk for schizophrenia are glutamatergic. Additionally, mice with reduced NMDA function have been utilized as models of schizophrenia (Mohn et al., 1999; see also SRF related news story).

The heteromultimeric NMDA receptor is composed of two NR1 and two NR2 subunits. NR1 is encoded by a single gene, while four genes encode NR2, producing subunits NR2A-D. During embryogenesis and early postnatal life, NMDA receptors exclusively contain NR1 and NR2B; NR2A incorporation occurs later in development (Monyer et al., 1994; Sheng et al., 1994). The study of the role of the NR2B subtype during development has been particularly difficult due to the lethality of NR2B knockout mice, as well as the fact that, in traditional models, loss of NR2B early in development also results in loss of all NMDA signaling. In the current study, Hall and colleagues have circumvented these issues by creating the "NR2B --> NR2A" mouse, which exhibits functional NMDA receptor current despite complete loss of the NR2B subunit.

Role of NR2B in AMPA receptor-mediated signaling
NMDA receptors primarily regulate synaptic strength through control of AMPA receptors (Esteban, 2008). To examine the role of NR2B loss on AMPA signaling, first author Chih-Chieh Wang and colleagues measured AMPA receptor-mediated current in cortical cultures from NR2B --> NR2A mice. They found that AMPA-mediated current was increased, consistent with prior data showing that NMDA receptor activation suppresses AMPA receptor function (Hall et al., 2007). In these animals, Wang and colleagues also observed a deficit in a protein translation-dependent form of homeostatic synaptic plasticity, the scaling of synaptic strength to maintain stability mediated in part by changes in AMPA receptor signaling (Turrigiano, 2008; Gainey et al., 2009). A similar deficit was observed in conditional NR2B knockout mice that lack NR2B only in the cortex and hippocampus, but have normal levels in subcortical regions, suggesting that the impaired homeostatic synaptic plasticity is due to a loss of NR2B rather than premature expression of NR2A. After further probing the mechanisms underlying NR2B-mediated regulation of AMPA receptor current, the researchers found that the regulation of protein translation was dependent on the mammalian/mechanistic target of rapamycin (mTOR) pathway, and also required an association between NR2B and α calcium-calmodulin kinase II (CaMKII).

Role of NR2B in social functioning
Behavioral testing of the NR2B --> NR2A animals revealed hyperlocomotion and reduced social exploratory behavior, as measured by a social approach assay. The researchers also examined conditional NR2B conditional knockout mice and observed similar locomotive and social deficits, suggesting (similar to the homeostatic synaptic plasticity data) that the behavioral effects observed are due to a loss of NR2B rather than early expression of NR2A. However, since NR2B --> NR2A mice performed worse on the social interaction task than the conditional NR2B knockouts, premature NR2A expression may also enhance the social deficit.

This study demonstrates that signaling through NR2A is unable to rescue the deficits produced by loss of NR2B, and points to the NR2B subunit as a crucial determinant of signaling through AMPA receptors, synaptic function, and social behavior.—Allison A. Curley.

Wang CC, Held RG, Chang SC, Yang L, Delpire E, Ghosh A, Hall BJ. A Critical Role for GluN2B-Containing NMDA Receptors in Cortical Development and Function. Neuron . 2011 Dec 8 ; 72(5):789-805. Abstract

Comments on News and Primary Papers
Comment by:  Stefan KolataKazu Nakazawa
Submitted 21 February 2012 Posted 21 February 2012

The original NMDA receptor (NMDAR) hypofunction theory of...  Read more

View all comments by Stefan Kolata
View all comments by Kazu Nakazawa
Submit a Comment on this News Article
Make a comment on this news article. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory  
*Login Email Address  
*Confirm Email Address  
*Confirm Password  
Remember my Login and Password?  
Get SRF newsletter with recent commentary?  
Enter the code as it is shown below:
This code helps prevent automated registrations.

I recommend the Primary Papers

Please note: A member needs to be both registered and logged in to submit a comment.


(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)


SRF News
SRF Comments
Text Size
Reset Text Size
Copyright © 2005- 2016 Schizophrenia Research Forum Privacy Policy Disclaimer Disclosure Copyright